Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Miki

Showing results (161-170 of 230) with videos related to

Pageof 23
Sort By:
Histology and Histopathology|July 23, 2021
D-2-hydroxyglutarate dehydrogenase in breast carcinoma as a potent prognostic marker associated with proliferationChiaki Hayashi, Kiyoshi Takagi, Ai Sato, et al.
Cancer Science|July 23, 2013
Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67Akiko Sato-Tadano, Takashi Suzuki, Masakazu Amari, et al.
Endocrine Pathology|February 3, 2009
An analysis of potential surrogate markers of target-specific therapy in archival materials of adrenocortical carcinomaMegumi Nakamura, Yasuhiro Miki, Jun-Ichi Akahira, et al.
Acta Histochemica Et Cytochemica|September 8, 2023
Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic PredictorAkiko Ebata, Takashi Suzuki, Narumi Shoji-Harada, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissuesYasuhiro Miki, Taisuke Nakata, Takashi Suzuki, et al.
Breast Cancer Research and Treatment|October 23, 2008
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trialMatthew J Ellis, William R Miller, Yu Tao, et al.
Scientific Reports|September 16, 2024
Prognostic significance and response to immune checkpoint inhibitors of RIPK3, MLKL and necroptosis in non-small cell lung cancerNattaya Duangthim, Thanpisit Lomphithak, Ryoko Saito-Koyama, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Nur-related factor 1 and nerve growth factor-induced clone B in human adrenal cortex and its disordersLiangying Lu, Takashi Suzuki, Yosuke Yoshikawa, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 26, 2014
Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factorNaoko Sato, Kiyoshi Takagi, Takashi Suzuki, et al.
Hormones & Cancer|October 1, 2013
Aryl hydrocarbon receptor in breast cancer—a newly defined prognostic markerRyoko Saito, Yasuhiro Miki, Shuko Hata, et al.
Pageof 23

Showing results (161-170 of 230) with videos related to

Sort By:
Pageof 23
Histology and Histopathology|July 23, 2021
D-2-hydroxyglutarate dehydrogenase in breast carcinoma as a potent prognostic marker associated with proliferationChiaki Hayashi, Kiyoshi Takagi, Ai Sato, et al.
Cancer Science|July 23, 2013
Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67Akiko Sato-Tadano, Takashi Suzuki, Masakazu Amari, et al.
Endocrine Pathology|February 3, 2009
An analysis of potential surrogate markers of target-specific therapy in archival materials of adrenocortical carcinomaMegumi Nakamura, Yasuhiro Miki, Jun-Ichi Akahira, et al.
Acta Histochemica Et Cytochemica|September 8, 2023
Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic PredictorAkiko Ebata, Takashi Suzuki, Narumi Shoji-Harada, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissuesYasuhiro Miki, Taisuke Nakata, Takashi Suzuki, et al.
Breast Cancer Research and Treatment|October 23, 2008
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trialMatthew J Ellis, William R Miller, Yu Tao, et al.
Scientific Reports|September 16, 2024
Prognostic significance and response to immune checkpoint inhibitors of RIPK3, MLKL and necroptosis in non-small cell lung cancerNattaya Duangthim, Thanpisit Lomphithak, Ryoko Saito-Koyama, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Nur-related factor 1 and nerve growth factor-induced clone B in human adrenal cortex and its disordersLiangying Lu, Takashi Suzuki, Yosuke Yoshikawa, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 26, 2014
Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factorNaoko Sato, Kiyoshi Takagi, Takashi Suzuki, et al.
Hormones & Cancer|October 1, 2013
Aryl hydrocarbon receptor in breast cancer—a newly defined prognostic markerRyoko Saito, Yasuhiro Miki, Shuko Hata, et al.
Pageof 23